A Needs Assessment for Infectious Diseases Consultation in Community Hospitals
Tóm tắt
Infectious diseases (ID) consultations have been demonstrated to improve patient outcomes in the treatment of severe infections. However, ID consultation is often unavailable to patients that live in rural communities. Little is known regarding the treatment of infections in rural hospitals with no coverage from an ID specialist. We characterized the outcomes of patients cared for in hospitals without coverage from an ID physician. Patients aged 18 years or older admitted to eight community hospitals without access to ID consultation during a 6.5-month period were assessed. All patients had received at least three days of continuous antimicrobial therapy. The primary outcome was the need for transfer to a tertiary facility for ID services. The secondary outcome was the characterization of antimicrobials received. Antimicrobial courses were evaluated independently by two board-certified ID physicians. 3706 encounters were evaluated. Transfers for ID consultation occurred in 0.01% of patients. The ID physician would have made modifications in 68.5% of patients. Areas for improvement included treatment of chronic obstructive pulmonary disease exacerbations, broad-spectrum treatment of skin and soft tissue infection, long courses of azithromycin, and management of Staphylococcus aureus bacteremia, including choice and length of therapy, as well as obtaining echocardiography. Patients evaluated received 22,807 days of antimicrobial therapy. Patients hospitalized in community hospitals are rarely transferred for ID consultation. Our work demonstrates a need for ID consultation in community hospitals, identifying opportunities to enhance patient care by modifying antimicrobial regimens to improve antimicrobial stewardship and avoid inappropriate antimicrobials. Efforts to expand the ID workforce to include coverage at rural hospitals will likely improve antibiotic utilization.
Tài liệu tham khảo
Lahey T, Shah R, Gittzus J, Schwartzman J, Kirkland K. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore). 2009;88(5):263–7. https://doi.org/10.1097/MD.0b013e3181b8fccb.
Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123(7):631–7. https://doi.org/10.1016/j.amjmed.2010.01.015.
Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46(7):1000–8. https://doi.org/10.1086/529190.
Fries BL, Licitra C, Crespo A, et al. Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2014;58(4):598–9. https://doi.org/10.1093/cid/cit730.
Robinson JO, Pozzi-Langhi S, Phillips M, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis. 2012;31(9):2421–8. https://doi.org/10.1007/s10096-012-1585-y.
Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation--a study of 521 patients in Germany. J Infect. 2009;59(4):232–239. https://doi.org/10.1016/j.jinf.2009.07.015
Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60(10):1451–61. https://doi.org/10.1093/cid/civ120.
Tissot F, Calandra T, Prod’hom G, et al. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality. J Infect. 2014;69(3):226–34. https://doi.org/10.1016/j.jinf.2014.05.004.
Chesdachai S, Kline S, Helmin D, Rajasingham R. The Effect of Infectious Diseases Consultation on Mortality in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus, Candida, and Pseudomonas Bloodstream Infections. Open Forum Infect Dis. 2020;7(1):ofaa010. https://doi.org/10.1093/ofid/ofaa010
Lee RA, Zurko JC, Camins BC, et al. Impact of infectious disease consultation on clinical management and mortality in patients with candidemia. Clin Infect Dis. 2019;68(9):1585–7. https://doi.org/10.1093/cid/ciy849.
Mejia-Chew C, O’Halloran JA, Olsen MA, et al. Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study. Lancet Infect Dis. 2019;19(12):1336–44. https://doi.org/10.1016/S1473-3099(19)30405-0.
Burnham JP, Olsen MA, Stwalley D, Kwon JH, Babcock HM, Kollef MH. Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections. Open Forum Infect Dis. 2018;5(3):ofy026. https://doi.org/10.1093/ofid/ofy026
Lee RA, Vo DT, Zurko JC, Griffin RL, Rodriguez JM, Camins BC. Infectious Diseases Consultation Is Associated With Decreased Mortality in Enterococcal Bloodstream Infections. Open Forum Infect Dis. 2020;7(3):ofaa064. https://doi.org/10.1093/ofid/ofaa064
Sharma R, Loomis W, Brown RB. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy. Am J Med Sci. 2005;330(2):60–4. https://doi.org/10.1097/00000441-200508000-00002.
Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM. Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. J Hosp Med. 2012;7(5):365–9. https://doi.org/10.1002/jhm.1902.
Walensky RP, McQuillen DP, Shahbazi S, Goodson JD. Where Is the ID in COVID-19? Ann Intern Med. 2020;173(7):587–9.
Advani SD, Sickbert-Bennett E, Moehring R, et al. The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce [published online ahead of print, 2022 Aug 23]. Clin Infect Dis. 2022;ciac684. https://doi.org/10.1093/cid/ciac684
Coombes CE, Gregory ME. The current and future use of telemedicine in infectious diseases practice. Curr Infect Dis Rep. 2019;21(11):41. https://doi.org/10.1007/s11908-019-0697-2.
Shively NR, Moffa MA, Paul KT, et al. Impact of a telehealth-based antimicrobial stewardship program in a community hospital health system. Clin Infect Dis. 2020;71(3):539–45. https://doi.org/10.1093/cid/ciz878.
dos Santos RP, Deutschendorf C, Carvalho OF, Timm R, Sparenberg A. Antimicrobial stewardship through telemedicine in a community hospital in Southern Brazil. J Telemed Telecare. 2013;19(1):1–4. https://doi.org/10.1177/1357633X12473901.
Stevenson LD, Banks RE, Stryczek KC, et al. A pilot study using telehealth to implement antimicrobial stewardship at two rural Veterans Affairs medical centers. Infect Control Hosp Epidemiol. 2018;39(10):1163–9. https://doi.org/10.1017/ice.2018.197.
Veillette JJ, Vento T, Gelman S, et al. Implementation of a centralized telehealth-based antimicrobial stewardship program (ASP) for 16 Small Community Hospitals (SCHs). Open Forum Infect Dis. 2017;4(Suppl 1):S278–9. https://doi.org/10.1093/ofid/ofx163.625.
Abdel-Massih, R. C., &Mellors, J. W. (2019, May). Telemedicine and ID Practice: A Leap Forward or a Step Back?. In Open forum ID (Vol. 6, No. 5, p. ofz196). US: Oxford University Press.
Rawson TM, Ming D, Ahmad R, Moore LSP, Holmes AH. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18(8):409–10. https://doi.org/10.1038/s41579-020-0395-y.
Nathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau C. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):1–3.
Rimawi RH, Mazer MA, Siraj DS, Gooch M, Cook PP. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med. 2013;41(9):2099–2107. https://doi.org/10.1097/CCM.0b013e31828e9863
McQuillen DP, MacIntyre AT. The Value That Infectious Diseases Physicians Bring to the Healthcare System. J Infect Dis. 2017;216(suppl_5):S588-S593. https://doi.org/10.1093/infdis/jix326